Gregory I Vladimer
8PUBLICATIONS
46CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (8)
Sort by Publication Date:
|Nov 21, 2022
Selective Inhibition of Bruton's Tyrosine Kinase by a Designed Covalent Ligand Leads to Potent Therapeutic Efficacy in Blood Cancers Relative to Clinically Used Inhibitors.Bárbara B Sousa, Cátia Rebelo de Almeida, Ana F Barahona
|Sep 20, 2022
Deep Morphology Learning Enhances Ex Vivo Drug Profiling-Based Precision Medicine.Tim Heinemann, Christoph Kornauth, Yannik Severin
|Oct 12, 2021
Functional Precision Medicine Provides Clinical Benefit in Advanced Aggressive Hematologic Cancers and Identifies Exceptional Responders.Christoph Kornauth, Tea Pemovska, Gregory I Vladimer
|Jan 30, 2019
Combined chemosensitivity and chromatin profiling prioritizes drug combinations in CLL.Christian Schmidl, Gregory I Vladimer, André F Rendeiro
|Jan 26, 2019
FOXO3 is involved in the tumor necrosis factor-driven inflammatory response in fibroblast-like synoviocytes.Bernhard Brandstetter, Karolina Dalwigk, Alexander Platzer
|Nov 17, 2018
LZTR1 is a regulator of RAS ubiquitination and signaling.Johannes W Bigenzahn, Giovanna M Collu, Felix Kartnig
Pageof 2
Frequent Collaborators
3 joint publications
Berend Snijder
3 joint publications
Stefan Kubicek
3 joint publications
Giulio Superti-Furga
3 joint publications
Tea Pemovska
2 joint publications
Johannes W Bigenzahn
2 joint publications
Tim Heinemann
1 joint publications
Nikolaus Krall
1 joint publications
Kilian V M Huber
1 joint publications
Gonçalo J L Bernardes
1 joint publications
Giovanna M Collu
